FANCM and breast cancer: Thus, we performed a meta-analysis combining results from these studies with those from our analysis and found that all FANCM MVs combined were associated with familial breast cancer risk with OR = 1.22 (95% CI 1.08–1.38; P = 0.002, Fig. 2).